US Patent Litigations are now available. Check here

Explore patent oppositions filed by Polpharma Biologics against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jun 26, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3237004Predicting Outcome Of Treatment With An Anti- 4 7 Integrin AntibodyMILLENNIUM PHARMACEUTICALSFeb 7, 2025
EP3339865Assay For Jc Virus AntibodiesBIOGEN MAMay 23, 2023
EP3575792Method Of Assessing Risk Of PmlBIOGEN MADec 1, 2022
EP3095463Methods For Treating Progressive Multiple SclerosisF HOFFMANN LA ROCHEJun 8, 2021
EP3264094Methods For Evaluating An Immune Response To A Therapeutic AgentBIOGEN MAMay 18, 2021
EP2676967Methods Of Treating Inflammatory And Autoimmune Diseases With NatalizumabBIOGEN IDEC MAMay 14, 2020
EP2715352Method Of Assessing Risk Of PmlBIOGEN IDEC MAJan 17, 2020